The Combination of Ruxolitinib (RUX) with Decitabine (DAC) in Patients (Pts) with Post-Myeloproliferative Neoplasm Acute Myeloid Leukemia (post-MPN AML): Interim Report of a Phase I/II Trial
Year: 2017
Type: article
Study design: Clinical Trial
Source: Blood
Authors: Rita Assi, Prithviraj Bose, Srđan Verstovšek, Yvonne Gasior, Nitin Jain, Elias Jabbour, Zeev Estrov, Yesid Alvarado, Courtney D. DiNardo, Naveen Pemmaraju, Steven M. Kornblau, Tapan M. Kadia, Naval Daver, Mark Brandt, Sherry Pierce, Xuelin Huang, Guillermo Garcia‐Manero, Hagop M. Kantarjian, Farhad Ravandi
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3096486308